The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of artificially inflating insulin prices.
The company put out a statement on Friday rejecting the allegations, but the Wall Street Journal article caused a 7.17% drop in the price of its stock.
The focus on comprehensive family wellbeing benefits is reshaping the workplace, offering employers a powerful tool to attract and retain top talent while mitigating rising health care costs.
The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will be another remarkable year in this journey.